Belinostat, at Its Clinically Relevant Concentrations, Inhibits Rifampicin Induced CYP3A4 and MDR1 Gene Expression
Molecular Pharmacology - United States
doi 10.1124/mol.118.114587
Full Text
Open PDFAbstract
Available in full text
Date
January 8, 2019
Authors
Publisher
American Society for Pharmacology & Experimental Therapeutics (ASPET)